Low Risk of US Tariffs on Indian Pharma: Citi Recommends Torrent Pharma and Divi's for Investors

Low Risk of US Tariffs on Indian Pharma:…

ByAbhinandanApr 1, 2025

Citi’s analysis suggests that the likelihood of the U.S. imposing…

JOIN US
Image Not Found

Get Newsletter

Subscribe our newsletter to get the best stories into your inbox!